ruxolitinib,dexamethasone
novartis,incyte
['ruxolitinib', 'leukemia', '2019', 'rux,(-crux),(-trux)', 'dexamethasone', 'rux,(-crux),(-trux),(-deruxtecan)']
congress #ash22 | manuel quadri discusses novel agents targeting jak2 rearrangements in pediatric b-cell precursor all. chz868, a new class-ii tyrosine kinase inhibitor was used to target jak2 resulting in a mean inhibition of -62% of py1007-1008 jak2 in pax5 #leukemia 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm